Search the Newsreel

Capri Global Capital to Host Q1 FY27 Earnings Conference Call on July 29

Capri Holdings Limited $CPRI Stock Position Lifted by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC increased its stake in Capri Holdings Limited (NYSE:CPRI) by 15.6% in the first quarter, now owning 640,980 shares valued at $11.5 million. Capri's stock opened at $16.12, near its 52-week low, and despite beating earnings estimates for the last …

Capricor Therapeutics (NASDAQ:CAPR) Share Price Crosses Below Two Hundred Day Moving Average - Here's Why

Capricor Therapeutics (NASDAQ:CAPR) shares recently fell below their 200-day moving average, trading as low as $18.98, significantly under the $27.65 average. Despite this, analyst sentiment remains largely positive with a consensus "Moderate Buy" rating and an average price target of $53.67. The company recently …

Capri Holdings Limited (NYSE:CPRI) Given Average Recommendation of "Hold" by Brokerages

Capri Holdings Limited (NYSE:CPRI) has received a consensus "Hold" rating from sixteen brokerage firms, with an average 12-month price target of $24.21. Recent analyst actions include price target cuts from JPMorgan, Barclays, Wells Fargo, and Bank of America, though some maintained "overweight" or "outperform" …

The Michael Kors Parker shoulder bag - Capri Holdings leans on quiet logo power

The Michael Kors Parker shoulder bag, characterized by its structured Saffiano leather and discreet logo, represents Capri Holdings' strategy in the mid-range handbag segment. This product aims to provide accessible premium options, balancing brand recognition with subtle styling, and contributes significantly to Michael Kors' …

Capri Holdings (CPRI) CMD 2025 Summary

Capri Holdings outlined its CMD 2025 strategy, focusing on maximizing its brands—Versace, Jimmy Choo, and Michael Kors—through tailored strategies and digital transformation. The company aims for group revenue to reach $6.3 billion by fiscal 2027 with high-teens operating margins, supported by $300 million in …

Capri Holdings (CPRI) Citi’s 2026 Global Consumer & Retail Conference 2026 Summary

Capri Holdings (CPRI) presented at Citi's 2026 Global Consumer & Retail Conference, outlining strategic initiatives to modernize Michael Kors and Jimmy Choo for Gen Z and millennials, including enhanced marketing and product strategies, and reduced discounting. The company reported significant debt reduction after the …

The Michael Kors Greenwich Medium Messenger - Capri Holdings bets on crafted crossbody practicality

The article highlights the Michael Kors Greenwich Medium Messenger bag, a compact crossbody launched by Capri Holdings, emphasizing its practical design, materials, and role in driving Capri Holdings' stock performance. It notes the bag's target demographic of urban consumers seeking a versatile daily accessory …

Capri Holdings Limited Announces Reporting Date For First Quarter Fiscal 2027 Financial Results

Capri Holdings Limited (NYSE: CPRI) announced it will report its first quarter fiscal 2027 financial results on Wednesday, August 5, 2026, at approximately 6:45 a.m. ET. The company will host a conference call the same day at 8:30 a.m. ET to discuss these results, …

Capri Holdings (CPRI) Strategy Update Summary

Capri Holdings provided a strategy update after its merger with Tapestry was terminated due to regulatory issues, forcing the company to refocus on independent growth for its Michael Kors, Versace, and Jimmy Choo brands. The company acknowledged recent disappointing financial results and outlined brand-specific …

ETFs Investing in Capri Holdings Limited Stocks

This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold stocks of Capri Holdings Limited (MKO). The list is sorted by market value and includes various details for each ETF, such as issuer, management style, focus, expense ratio, and performance metrics. …

Can Capricor Therapeutics’ (CAPR) FDA-Linked HQ Expansion Reshape Its Risk Profile And Strategic Flexibility?

Capricor Therapeutics has leased a new 171,000 sq ft headquarters in San Diego, contingent on FDA approval of its drug Deramiocel for Duchenne muscular dystrophy by December 31, 2026. This significant expansion directly ties the company's future facilities to a critical regulatory outcome, underscoring …

Capri Holdings | SCHEDULE 13G/A: Others

This article consists of a document filed by Capri Holdings, identified as a SCHEDULE 13G/A, which is a regulatory filing indicating beneficial ownership of securities. The specific content of the document is not provided, but it is categorized under "Others."

Michael Kors Greenwich Medium Shoulder Bag by Capri Holdings Ltd. - compact leather revenue driver

The Michael Kors Greenwich Medium Shoulder Bag, produced by Capri Holdings Ltd., is highlighted as a significant revenue driver due to its compact leather design and practical organization. Although not a runway piece, it targets repeat buyers in the everyday handbag segment, contributing to …

Capricor Therapeutics (CAPR) Signs Expansion Lease Tied To Deramiocel FDA Approval

Capricor Therapeutics has signed a major headquarters relocation and expansion lease directly linked to the potential FDA approval of its lead therapy, Deramiocel, for Duchenne muscular dystrophy. This strategic move aligns Capricor's future operational growth, including expanded manufacturing and research facilities, with the regulatory …

ETFs Investing in Capricor Therapeutics, Inc. Stocks

This article lists various ETFs that include Capricor Therapeutics, Inc. (4LN2) stocks in their portfolios. It provides a detailed table outlining each ETF's market value, weight, issuer, management style, expense ratio, AUM, price, change percentage, relative volume, and 3-year NAV total return. The ETFs …

Capri Holdings (CPRI) Unveils Post Versace Plan Focused On Michael Kors And Jimmy Choo

Capri Holdings (CPRI) has announced a new strategy focusing on its Michael Kors and Jimmy Choo brands following its post-Versace plan. The company aims to restore profitability at Jimmy Choo by fiscal 2027 through store updates, targeted marketing, and product development for younger shoppers. …

Cantor Fitzgerald reiterates Overweight on Capricor stock at $62

Cantor Fitzgerald has reiterated an Overweight rating and a $62.00 price target for Capricor Therapeutics (NASDAQ:CAPR). The firm anticipates FDA approval for deramiocel, a Duchenne muscular dystrophy treatment, following its August 22 PDUFA date and plans to discuss early launch dynamics and commercial conversion …

Is Capri’s Shift Into Russell Growth Indices Reshaping Its Style Identity And Funding Mix (CPRI)?

Genel to buy Capricorn Energy in $360 million cash deal - UPDATE

Is Capri Holdings (CPRI) Cheap As Earnings Beat And Guidance Lift Growth Hopes?

CGCL Forecast — Price Target — Prediction for 2027

Capri Holdings (CPRI) Down 4.5% Since Last Earnings Report: Can It Rebound?

Capri Global Schedules Overseas Investor Meetings for Late June 2026

Capri Global Capital to host analyst meet on June 16

CAPRI HOLDINGS ($CPRI) Releases Q4 2026 Earnings

Capri Holdings (CPRI) Q4 Earnings Surpass Estimates

Capri Holdings Shares Gain After Earnings Beat and Signs of Turnaround Progress (CPRI)

Seeking Clues to Capri Holdings (CPRI) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Capri Global Files May 2026 Investor Presentation

Growth Investors: Industry Analysts Just Upgraded Their Capri Global Capital Limited (NSE:CGCL) Revenue Forecasts By 17%

Capri Global Capital Stock Climbs on Analyst Upgrade; Valuation Eyed

Capricorn Energy Clears Debt Early on Back of Robust Egyptian Payments

Capri Global AUM Tops Rs 36,000 Crore as FY26 Profit Nearly Doubles

Capri Global Capital shares fall after launching ₹500 crore public NCD issue; check dates, coupon details

Should You Trade Caprice Resources (ASX: CRS) Amid Rising Volatility?